Spontaneous Urticaria
📧 Sign up to get email alerts when something new happens for Spontaneous Urticaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-06Clinical Trial Results: Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine [Phase 2]
Phase 2 clinical trial evaluating rilzabrutinib for chronic spontaneous urticaria in patients who remain symptomatic despite H1 antihistamin…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension. [Phase 3]
Phase 3b study evaluating remibrutinib vs placebo with omalizumab as active control in adult chronic spontaneous urticaria, with an optional…
-
CLINICAL_TRIALS trial_result · 2026-06-03Clinical Trial Update: A Study of Efficacy and Safety of TLL-018 in CSU Participants [Phase 3]
Phase 3 study update on the efficacy and safety of TLL-018 in chronic spontaneous urticaria (CSU) is currently active, not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: Phase 2 Study of Lesigercept in Adult Patients With Chronic Spontaneous Urticaria Who Are Inadequately Controlled by H1-Antihistamines [Phase 2]
Phase 2 clinical trial evaluating Lesigercept for adults with chronic spontaneous urticaria inadequately controlled by H1 antihistamines; cu…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria [Phase 3]
A Phase 3 clinical trial evaluating Barzolvolimab for chronic spontaneous urticaria is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-12Clinical Trial Update: Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 clinical trial update reporting efficacy and safety data for povorcitinib in adults with chronic spontaneous urticaria; results comp…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib [Phase 3]
An extension Phase 3 study evaluating long-term efficacy, safety, and tolerability of remibrutinib in chronic spontaneous urticaria patients…
-
CLINICAL_TRIALS trial_result · 2026-03-11Clinical Trial Update: A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines [Phase 3]
Phase 3 clinical trial evaluating remibrutinib versus dupilumab at early timepoints in adults with chronic spontaneous urticaria inadequatel…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: Effects of Diet and Oxidative Stress on Disease Severity and Response to Omalizumab in Chronic Spontaneous Urticaria
This clinical trial update indicates ongoing enrollment for a study investigating how diet and oxidative stress affect disease severity and …
-
CLINICAL_TRIALS trial_result · 2026-02-04Clinical Trial Update: A Real-world Study to Assess Safety and Effectiveness of Xolair® in Pediatric Chronic Spontaneous Urticaria in China
A completed real-world study in China evaluated the safety and effectiveness of omalizumab (Xolair) for pediatric chronic spontaneous urtica…
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: Evaluate Safety and Pharmacokinetics of INF904 in Subjects With Moderate to Severe Chronic Spontaneous Urticaria or Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of INF904 in adults with chronic spontaneous urticaria or hidradenitis suppurativa was …
-
CLINICAL_TRIALS trial_result · 2026-01-26Clinical Trial Update: Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria [NA]
Completed clinical trial comparing high-dose bilastine (40 mg) to bilastine (20 mg) plus levocetirizine (5 mg) for chronic spontaneous urtic…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU) [Phase 1, Phase 2]
This is a dose-escalation study evaluating safety, pharmacokinetics/pharmacodynamics, and preliminary clinical activity of briquilimab in ad…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: Efficacy and Safety of LP-003 in Patients With CSU Who Remain Symptomatic Despite Antihistamine (H1) Treatment [Phase 2]
This Phase 2 trial update reports efficacy and safety data for LP-003 in adults with chronic spontaneous urticaria who remain symptomatic de…
-
CLINICAL_TRIALS trial_result · 2025-12-12Clinical Trial Update: A Study of Single and Multiple Doses of LP-003 in Healthy Adult Participants [Phase 1]
A Phase 1 study evaluating single and multiple doses of LP-003 in healthy adult participants has completed, focusing on safety, tolerability…
-
CLINICAL_TRIALS trial_result · 2025-12-05Clinical Trial Update: Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria [Phase 2]
A Phase 2 multicenter randomized trial of EP262 for chronic spontaneous urticaria was terminated, and the results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU) (LIBERTY-CSU CUPIDKids) [Phase 3]
A Phase 3 pharmacokinetics and safety study of dupilumab in children aged 2 to under 12 with uncontrolled chronic spontaneous urticaria has …
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: An Outpatient Study of the Efficacy of ARS-2 in Patients With Chronic Spontaneous Urticaria [Phase 2]
Phase 2 outpatient trial evaluating ARS-2 for chronic spontaneous urticaria, currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Mepolizumab for the Treatment of Chronic Spontaneous Urticaria [EARLY_Phase 1]
An early Phase 1 trial evaluating mepolizumab for chronic spontaneous urticaria has completed enrollment and posted results in 2025.
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Open-Label Extension Study for Subjects With H1 Antihistamine Refractory Chronic Spontaneous Urticaria Completing Study AK006-001 [Phase 1]
An open-label extension study (AK006-001) for subjects with H1 antihistamine-refractory chronic spontaneous urticaria has completed Phase 1.
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) [Phase 3]
Phase 3 trial LIBERTY-CSU CUPID evaluated dupilumab for chronic spontaneous urticaria in patients who remained symptomatic despite H1 antihi…
-
CLINICAL_TRIALS trial_result · 2025-07-29Clinical Trial Update: To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria [Phase 3]
Phase 3 trial comparing CT-P39 to EU-approved Xolair (omalizumab) in chronic spontaneous urticaria; results have been completed and posted.
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous Urticaria [Phase 1]
A Phase 1 study update reports completion of evaluating AK006 for safety, tolerability, pharmacokinetics, and immunogenicity in healthy part…
-
CLINICAL_TRIALS trial_result · 2025-04-30Clinical Trial Update: A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks. [Phase 3]
A multicenter Phase 3 open-label trial evaluating remibrutinib added to H1-antihistamines for adults with chronic spontaneous urticaria inad…
-
CLINICAL_TRIALS trial_result · 2025-03-26Clinical Trial Update: A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous Urticaria [Phase 2]
This document reports the completion of a Phase 2 trial evaluating CDX-0159 in patients with chronic spontaneous urticaria. The study status…